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Abstract 
Background: Malaria is a public health threat in Yemen, with 149,451 cases being reported in 2013. Of these, Plas-
modium falciparum represents 99 %. Prompt diagnosis by light microscopy (LM) and rapid diagnostic tests (RTDs) is 
a key element in the national strategy of malaria control. The heterogeneous epidemiology of malaria in the country 
necessitates the field evaluation of the current diagnostic strategies, especially RDTs. Thus, the present study aimed 
to evaluate LM and an RDT, combining both P. falciparum histidine‑rich protein‑2 (PfHRP‑2) and Plasmodium lactate 
dehydrogenase (pLDH), for falciparum malaria diagnosis and survey in a malaria‑endemic area during the transmis‑
sion season against nested polymerase chain reaction (PCR) as the reference method.
Methods: A household‑based, cross‑sectional malaria survey was conducted in Mawza District, a malaria‑endemic 
area in Taiz governorate. A total of 488 participants were screened using LM and PfHRP‑2/pLDH RDT. Positive samples 
(160) and randomly selected negative samples (52) by both RDT and LM were further analysed using 18S rRNA‑based 
nested PCR.
Results: The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the RDT 
were 96.0 % (95 % confidence interval (CI): 90.9–98.3), 56.0 % (95 % CI: 44.7–66.8), 76.3 % (95 % CI: 69.0–82.3), and 
90.4 % (95 % CI: 78.8–96.8), respectively. On the other hand, LM showed sensitivity of 37.6 % (95 % CI: 29.6–46.3), 
specificity of 97.6 % (95 % CI: 91.7–99.7), PPV of 95.9 % (95 % CI: 86.3–98.9), and NPV of 51.3 % (95 % CI: 43.2–59.2). 
The sensitivity of LM dropped to 8.5 % for detecting asymptomatic malaria. Malaria prevalence was 32.8 % (32.1 and 
37.5 % for ≥10 and <10 years, respectively) with the RDT compared with 10.7 % (10.8 and 9.4 % for age groups of ≥10 
and <10 years, respectively) with LM. Among asymptomatic malaria individuals, LM and RDT‑based prevalence rates 
were 1.6 and 25.6 %, respectively. However, rates of 88.2 and 94.1 % of infection with P. falciparum were found among 
patients who reported fever in the 48 h prior to the survey by LM and PfHRP‑2/pLDH RDT, respectively.
Conclusions: The PfHRP‑2/pLDH RDT shows high sensitivity for the survey of falciparum malaria even for asympto‑
matic malaria cases. Although the RDT had high sensitivity, its high false‑positivity rate limits its utility as a single diag‑
nostic tool for clinical diagnosis of malaria. On the other hand, low sensitivity of LM indicates that a high proportion 
of malaria cases is missed, underestimating the true prevalence of malaria in the community. Higher NPV of PfHRP‑2/
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Background
Malaria is a public health threat causing morbidity and 
mortality in Yemen, with Plasmodium falciparum being 
the predominant species responsible for almost 99 % of 
cases. It is estimated that 43  % of the population are at 
high risk and a total of 63,484 microscopy-confirmed and 
39,294 rapid diagnostic test (RDT)-confirmed cases were 
reported in 2013 [1]. Yemen is in the control phase, and 
the adopted malaria control strategies include distribut-
ing insecticide-treated nets, indoor residual spraying, 
prompt diagnosis and treatment with artemisinin-based 
combination therapy [2].
Light microscopy (LM) is still the cornerstone of 
malaria diagnosis in Yemen, especially in hospitals. How-
ever, LM has low sensitivity for detection of low para-
site densities, is time-consuming and requires skilled 
technicians and good reagents [2, 3]. Therefore, it may 
not reflect the submicroscopic infectious reservoir in 
Yemen, which is still neglected and needs to be estimated 
if malaria elimination in the country is to be achieved 
[4]. RDTs have been introduced as an alternative to 
LM, especially when good LM practice cannot be main-
tained or is not available. RDTs that target P. falciparum 
histidine-rich protein-2 (PfHRP-2) have the highest and 
most consistent detection rate [5]. In contrast, Plasmo-
dium lactate dehydrogenase (pLDH) detects all Plasmo-
dium species and is usually combined with PfHRP-2 for 
malaria screening in areas endemic with multiple species 
[6, 7]. The National Malaria Control Programme (NMCP) 
has been using RDTs for malaria diagnosis and field sur-
veys since 2007 [2, 8]. Although the World Health Organ-
ization (WHO) has provided comparative data on the 
performance of RDTs that can be used for procurement 
decision, it is well recognized that clinical sensitivity of 
RDTs depends on the epidemiology of malaria in the tar-
get population [5], which imposes field evaluation of such 
tests. In Yemen, malaria is unstable, seasonal and affected 
by topography and rainfall. The country has been strati-
fied with respect to malaria endemicity into four strata 
that are different in altitude, intensity, length, and season 
of transmission and even in the predominant vector spe-
cies [2]. This heterogeneous epidemiology of malaria may 
affect the performance of RDTs, necessitating the need 
for their evaluation in the four strata. In Yemen, only two 
previous studies evaluated the performance of PfHRP-2-
based RDTs against LM as the ‘gold standard’ [9, 10]. It is, 
however, noteworthy that false-negativity of LM limits its 
accuracy as reference method. Polymerase chain reaction 
(PCR) is more sensitive than LM and RDTs for detect-
ing malaria in epidemiological studies assessing asymp-
tomatic carriers in low endemicity settings [11–13]. This 
is the first community-based survey to evaluate the per-
formance of LM and a PfHRP-2/pLDH RDT for malaria 
diagnosis against PCR as the reference method during 




The present study is a cross-sectional study in Mawza 
District, which is a malaria-endemic area located in Taiz 
governorate, south of Yemen (Fig.  1). Its total area is 
about 665  sq  km and is inhabited by a total population 
of 119,818 people. It has a coastal climate that is warm 
in winter and  hot in summer, with irregular heavy tor-
rents of rainfall. The mean temperature is 29  °C, and 
the humidity reaches 67  %. Peak malaria transmission 
occurs between October and April. The area is classified 
by the NMCP as belonging to stratum one, which has an 
altitude of less than 600 m and is characterized by high 
malaria transmission [2, 8, 14].
Ethical clearance and field survey
The protocol of the study was approved by the Ethi-
cal Committee of the University of Science and Tech-
nology, Yemen. This study recruited 488 participants 
through a household-based survey in the period from 
October 2013 to April 2014. All family members, of all 
age groups and both sexes, were invited to participate 
on a voluntary basis from randomly selected houses in 
the study area. Signed or thumb-printed informed con-
sent was taken from the participants or their guardians 
before sample collection and after a clear explanation 
of the study objectives. Data on the age of participants, 
history of anti-malarial drug intake 1  week prior to the 
study, and history of fever 48 h before the study were col-
lected using a pre-designed questionnaire. Whole blood 
samples (about 5 ml) were collected in EDTA tubes from 
all participants that were tested for malaria by using both 
RDT and LM. Haemoglobin was measured using Sysmex 
KX-21N Hematology Analyzer (Sysmex Corp, Chuo-Ku, 
Kobe, Japan). RDT-positive participants were treated 
according to the national malaria treatment policy of the 
Ministry of Health and Population, Yemen. For molecular 
pLDH RDT than LM can give a straightforward exclusion of malaria among febrile patients, helping to avoid unneces‑
sary presumptive treatments.
Keywords: Plasmodium falciparum, Microscopy, Rapid diagnostic test, Nested PCR, Yemen
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investigation, blood spots were blotted onto Whatmann® 
3MM filter papers, air-dried and kept in separate plastic 
bags at room temperature until DNA extraction.
LM and RDT screening
Thick and thin blood films (one slide per sample) were 
prepared and stained with Giemsa for approximately 
20  min according to standard procedures. Thick films 
were examined using a light microscope by a qualified 
laboratory technician for a minimum of 100 high-mag-
nification fields before being recorded as negative for 
malaria parasites. These films were then blindly exam-
ined by an independent malaria microscopist for the 
confirmation of the first examination. A third blinded 
examination was conducted for those films having dis-
cordant results between the first and second examin-
ers. The results for the third examination were regarded 
as final. All microscopists in this study were trained by 
the NMCP. Parasite density per μL of blood was esti-
mated for each sample by counting the number of par-
asites against 200 white blood cells (WBC), assuming 
a standard mean WBC count of 8000/μL blood [15]. 
Samples were then categorized into three groups based 
on parasite density; low (1–999 parasites/µL), moderate 
(1000–9999 parasites/µL) and high (>10,000 parasites/
μL) [16].
The SD Bioline® Malaria Antigen Pf/Pan test, product 
code: SD05FK63 (Standard Diagnostics, Inc, Kyonggi, 
Korea) that combines the detection of PfHRP-2 and 
pLDH was used based on the WHO recommendations as 
being one of the ten top-performing RDTs [17]. Test kits 
were kept at room temperature, in compliance with the 
manufacturer’s instructions, and tests were performed 
following the manufacturer’s instruction by using 5 µL of 
whole blood samples. RDT results were read and inter-
preted within 15–30 min according to the manufacturer’s 
instructions.
DNA extraction and molecular detection
Genomic DNA was extracted from dried blood spots by 
using DNeasy® Blood and Tissue Kit (QIAGEN, Hilden, 
Germany) according to the manufacturer’s instructions 
and kept at −20 °C until used. Genus- and species-spe-
cific nested PCR assays based on the 18S rRNA gene 
were used to detect and identify P. falciparum [18]. PCR 
for primary and secondary reactions were run in a total 
of 25  μL reaction mixture containing 4  μL template, 
200 μM of each deoxynucleotide triphosphate (dNTP), 
Fig. 1 Map of Yemen showing the study area
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4  mM MgCl2, 200  nM of each primer and 1  U of Taq 
polymerase. The cycling conditions for primary PCR 
were as follows: an initial denaturation step at 94 °C for 
4  min, then 35 cycles at 94  °C for 1  min, annealing at 
55  °C for 1  min and extension at 72  °C for 1  min, and 
a final extension at 72  °C for 10  min. Secondary PCR 
used similar cycling conditions except that the anneal-
ing temperature was increased to 58  °C. PCR products 
were separated by electrophoresis on 1.5 % agarose gel 
and stained with SYBR® Safe DNA Gel Stain (Invitro-
gen™, CA, USA).
Statistical analysis
Data obtained were entered and analysed using the Sta-
tistical Package for Social Sciences (SPSS) version 20.0 
(SPSS Inc, Chicago, IL, USA). The sensitivity, specificity, 
positive predictive value (PPV), and negative predictive 
value (NPV) of the RDT and LM were calculated against 
the nested PCR with their 95  % confidence intervals 
(CIs). Cohen’s kappa coefficient (Kc) was used to assess 
agreement between results obtained by two different 
tests [19], and the strength of agreement was scaled as 
follows: slight (Kc  =  0.01–0.20), fair (Kc  =  0.21–0.40), 
moderate (Kc = 0.41–0.60), substantial (Kc = 0.61–0.8), 
or almost perfect (Kc =  0.81–1) [20]. Statistical signifi-
cance was considered at p < 0.05.
Results
Characteristics of study subjects and prevalence of of 
malaria based on LM and PfHRP‑2/pLDH RDT
Of 488 participants, 35.2 % were males and 64.8 % were 
females. The median age of participants was 26 years old 
(interquartile range: 22–28 years). About 10.5 % (51/488) 
of participants had self-reported fever. The majority of 
participants (42  %; 205/488) were anaemic, having hae-
moglobin levels less than 11 g/dL. LM detected falcipa-
rum malaria among 10.7 % (10.8 and 9.4 % for age groups 
of ≥10 and <10 years, respectively) of patients. Of them, 
9.6 % (5/52) had a low parasitaemia, 32.7 % (17/52) had a 
moderate parasitaemia, 42.3 % (22/52) had a high para-
sitaemia and 15.4  % (8/52) showed only gametocytes. 
On the other hand, the overall prevalence of P. falcipa-
rum among the inhabitants of Mawza District was 32.8 % 
based on PfHRP-2/pLDH RDT (32.1 and 37.5 % for ≥10 
and <10  years, respectively). The prevalence was four 
times higher among children <10 years old with the RDT 
than with LM. Asymptomatic falciparum malaria among 
the study population was found to be 1.6 % with LM com-
pared with 25.6 % with the RDT. However, rates of 88.2 
and 94.1  % of infection with P. falciparum were found 
among patients who reported fever in the 48 h prior to 
the survey by LM and PfHRP-2/pLDH RDT, respectively 
(Table 1).
Comparison between PfHRP‑2/pLDH RDT and LM
Table  2 shows that PfHRP-2/pLDH RDT detected all 
LM-positive cases of falciparum malaria, irrespective 
of parasite density. Of the LM-negative samples, 24.6  % 
(107/435) were RDT-positive. RDT and LM showed 
a fair agreement (77.8 %; Kc = 0.379, p < 0.001) for the 
detection of P. falciparum among all participants. How-
ever, the two tests had a substantial agreement (94.1  %; 
Kc = 0.638, p < 0.001) for detecting the infection among 
febrile patients (Table 2).
Sensitivity, specificity, positive, and negative predictive 
values of PfHRP‑2/pLDH RDT against nested PCR
Compared with nested PCR, the PfHRP-2/pLDH RDT 
had sensitivity of 96.0 % (95 % CI: 90.9–98.3) and speci-
ficity of 56.0 % (95 % CI: 44.7–66.8), PPV of 76.3 % (95 % 
CI: 69.0–82.3), and NPV of 90.4 % (95 % CI: 78.8–96.8). 
The two types of tests showed a moderate degree of 
agreement (79.8  %; Kc =  0.553, p  <  0.001). In addition, 
the RDT maintained its high sensitivity for the detection 
of P. falciparum among children <10 years old, asympto-
matic participants and those with history of anti-malarial 
drug intake. However, it showed low specificity, which 
dropped to about 30  % among people with history of 
anti-malarial drug intake (Table 3).
Sensitivity, specificity, positive, and negative predictive 
values of LM against nested PCR
Compared with nested PCR, LM had sensitivity of 37.6 % 
(95  % CI: 29.6–46.3), specificity of 97.6  % (95  % CI: 
91.7–99.7), PPV of 37.6 % (95 % CI: 29.6–46.3), and NPV 
of 51.3  % (95  % CI: 43.2–59.2). The two types of tests 
Table 1 Prevalence of  Plasmodium falciparum based 
on LM and PfHRP-2/pLDH RDT screening in Mawza District, 
Taiz Governorate, Yemen
n number positive, CI confidence interval LM light microscopy PfHRP-2  
P. falciparum histidine-rich protein-2, pLDH Plasmodium lactate dehydrogenase, 
RDT rapid diagnostic test
LM PfHRP‑2/pLDH RDT
No n % (95 % CI) n % (95 % CI)
Overall 488 52 10.7 (8.2–13.7) 160 32.8 (28.8–37.1)
Age (years)
 ≥10 424 46 10.8 (8.2–14.2) 136 32.1 (27.8–36.7)
 <10 64 6 9.4 (4.4–19.0) 24 37.5 (26.7–49.8)
Fever 48 h prior to screening
 Yes 51 45 88.2 (76.6–94.5) 48 94.1 (84.1–98.0)
 No 437 7 1.6 (1.0–3.3) 112 25.6 (21.8–29.9)
History of anti‑malarial drug intake 1 week prior to the survey
 Yes 157 20 13.0 (9.0–19.0) 76 48.0 (41.0–56.0)
 No 331 32 10.0 (7.0–13.0) 84 25.0 (21.0–30.0)
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showed a fair degree of agreement (61.7 %; Kc =  0.307, 
p  <  0.001). A reduction in LM sensitivity was observed 
among children <10  years old, asymptomatic partici-
pants and those with history of anti-malarial drug intake. 
Although LM showed high sensitivity (93.5 %) for detect-
ing symptomatic malaria, such sensitivity dropped to 
8.5  % in case of asymptomatic malaria. On the other 
hand, LM maintained its high specificity for the detec-
tion of P. falciparum (Table 4).
Discussion
Prompt malaria diagnosis is a key component of the 
national malaria control strategy in Yemen, which relies 
on the use of LM and RDTs. This study was designed to 
evaluate the diagnostic accuracy of these two methods 
against nested PCR in Mawza District, Taiz Governo-
rate during the peak seasonal transmission. In the pre-
sent study, the PfHRP-2/pLDH RDT and LM showed a 
fair level of agreement in their performance to detect P. 
falciparum in the field, despite approaching 80 %. How-
ever, a substantial agreement was observed between RDT 
and LM for the detection of P. falciparum among febrile 
patients. This is consistent with a recent study [10] that 
reported a very good level of agreement between LM and 
CareStart™ HRP-2 RDT results among febrile patients. In 
the present study, RDT proved effective in detecting all 
LM-positive cases and in detecting a large proportion of 
LM-negative cases. The investigated RDT showed higher 
Table 2 Comparison between PfHRP-2/pLDH RDT and LM for detecting Plasmodium falciparum malaria in Mawza District, 
Taiz Governorate, Yemen
PfHRP-2 P. falciparum histidine-rich protein-2, pLDH Plasmodium lactate dehydrogenase, RDT rapid diagnostic test, LM light microscopy0, Kc Cohen’s kappa 
coefficient;  % agreement was calculated by summation of the number of positives and negatives by both RDT and LM divided by the total number of cases
LM
RDT Positive Negative Total % Agreement (Kc) p value
Overall Positive 52 108 160 77.9 (0.390) <0.001
Negative 0 328 328
Total 52 436 488
Febrile Positive 45 3 48 94.0 (0.638) <0.001
Negative 0 3 3
Total 45 6 51
Afebrile Positive 7 105 112 76.0 (0.090) <0.001
Negative 0 325 325
Total 7 430 437
Table 3 Sensitivity, specificity, PPV and NPV of PfHRP-2/pLDH RDT for detecting Plasmodium falciparum against nested 
PCR as a reference method
CI confidence interval, PfHRP-2 P. falciparum histidine-rich protein-2, pLDH Plasmodium lactate dehydrogenase, RDT rapid diagnostic test, PCR polymerase chain 
reaction, PPV positive predictive value, NPV negative predictive value, Kc Cohen’s kappa coefficient;  % agreement was calculated by summation of the number of 
positives and negatives by both RDT and PCR divided by the total number of cases
* The agreement between RDT and PCR was significant for all categories with p < 0.001
a Parasite densities of these two cases were 80 parasites and 400 parasites/µL
PCR + ve PCR + ve PCR−ve PCR−ve Sensitivity Specificity PPV NPV % Agreement*
RDT + ve RDT−ve RDT−ve RDT + ve % (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI) (Kc)
Overall 119 5 47 37 96.0 (90.9–98.3) 56.0 (44.7–66.8) 76.3 (69.0–82.3) 90.4 (78.8–96.8) 79.8 (0.553)
Age (years) (n = 208)
 ≥10 100 5 41 32 95.2 (89.3–97.9) 56.2 (44.1–67.8) 75.8 (67.8–82.3) 89.1 (76.4–96.4) 79.2 (0.545)
 <10 19 0 6 5 100 (82.4–100) 54.6 (23.4–83.3) 79.2 (57.9–92.9) 100 (54.1–100) 83.3 (0.603)
Fever 48 h prior to survey (n = 208)
 Yes 42 0 2 2a 100 (92.3–100) 50.0 (6.8–93.2) 95.5 (84.9–98.7) 100 (15.8–100) 95.3 (0.646)
 No 77 5 45 35 93.9 (86.3–98.0) 56.3 (44.7–67.3) 68.8 (59.3–77.2) 90.0 (78.2–96.7) 75.3 (0.504)
History of anti‑malarial drug intake 1 week prior to the survey (n = 207)
 Yes 52 2 9 21 96.3 (87.5–99.0) 30 (14.7–49.4) 71.2 (60.0–80.3) 81.8 (48.2–97.7) 72.6 (0.306)
 No 66 3 38 16 95.7 (88.0–98.5) 70.4 (57.2–80.9) 80.5 (70.6–87.6) 92.7 (80.6–97.5) 84.6 (0.678)
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sensitivity than LM compared with nested PCR (96.0 vs 
37.6 %), which is also higher than the sensitivity recom-
mended by the WHO [5].
The good performance of the PfHRP-2/pLDH RDT in 
the field is evidently shown by its ability to detect P. fal-
ciparum in all different degrees of microscopic parasite 
densities. Moreover, its sensitivity exceeds that of LM for 
parasite detection (93.9 vs 8.5  %) among afebrile partici-
pants, indicating its utility in active case detection. This 
could help in strategies for reducing malaria transmission 
by identifying asymptomatic carriers and their subsequent 
treatment. Similar findings of higher RDT sensitivity have 
been reported previously [21]. The WHO has recently 
demonstrated a good level of sensitivity of RDTs in low 
parasitaemia [5]. However, one should consider that not 
all RDT-positive cases correlated with those obtained by 
PCR. This in turn indicates that despite the better perfor-
mance of RDT compared with LM, false positivity of RDT 
could not be ruled out. However, its performance is still 
superior to that of LM. In this respect, a moderate agree-
ment (about 80 %) exists between RDT and PCR in detect-
ing falciparum malaria among Yemeni patients in the field 
compared with a fair agreement (about 62 %) between LM 
and PCR. Most importantly, the PfHRP-2/pLDH RDT 
showed a higher NPV than LM (90.4 vs 51.3 %) during the 
peak seasonal transmission of malaria. This is advanta-
geous for the definite exclusion of malaria among patients, 
and the avoiding of unnecessary presumptive treatments. 
Given that the NPV is 100.0  % for the RDT and 40.0  % 
for LM among febrile patients, RDT-negative results for 
patients experiencing fever will be straightforward and 
will rationalize the prescription of anti-malarial drugs. 
Similarly, a very recent study [22] recommends the use of 
RDTs for diagnosis of suspected malaria among sympto-
matic pregnant women but not for asymptomatic cases 
in Papua New Guinea. A limitation of the present study is 
that it included only a subset of the negative samples for 
molecular analysis. However, the large difference between 
RDT-positive and LM-positive samples, which is still of 
suspected positivity and could be due to persistent antige-
naemia (108 samples of the RDT-positive ones), helps to 
avoid or, at least, reduce any possible bias.
The superiority of RDTs compared with LM could 
be explained by the fact that sequestered P. falciparum 
missed by LM can be detected by RDTs because of the 
release of PfHRP-2 by parasites and its circulation in the 
blood [23, 24]. Meanwhile, the low sensitivity of LM in 
the present study could also be attributed to the high 
proportion of asymptomatic, very low-parasite density 
malaria cases. RDTs targeting PfHRP-2 have been sug-
gested as a better alternative to LM in areas of low-den-
sity parasitaemia and their false positives compared with 
LM have been confirmed by PCR to be cases below the 
threshold detection of LM [25]. In addition to the diag-
nostic limitation imposed by microscopist expertise, the 
poor-quality LM in developing countries contributes to 
its low sensitivity in detecting low-parasite density infec-
tions. In Yemen, poor performance of LM for malaria 
diagnosis has been ascribed to low quality reagents, labo-
ratory equipment and supplies [2]. LM of low quality has 
been reported to influence its sensitivity and specificity 
for malaria diagnosis [3].
In contrast, LM had higher overall specificity than RDT 
(97.6 vs 56 %) compared with the reference method. LM 
Table 4 Sensitivity, specificity, PPV and NPV of LM for detecting Plasmodium falciparum against nested PCR as a refer-
ence method
CI confidence interval, PCR polymerase chain reaction, LM light microscopy, PPV positive predictive value, NPV negative predictive value, Kc Cohen’s kappa coefficient; 
% agreement was calculated by summation of the number of positives and negatives by both LM and PCR divided by the total number of cases
* The agreement between LM and PCR was significant in all categories with p < 0.05
a Parasite densities of these two cases were 80 parasites and 400 parasites/µL
PCR + ve PCR + ve PCR−ve PCR−ve Sensitivity Specificity PPV NPV % Agreement*
LM + ve LM−ve LM−ve LM + ve % (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI) (Kc)
Overall 47 78 82 2a 37.6 (29.6–46.3) 97.6 (91.7–99.7) 95.9 (86.3–98.9) 51.3 (43.2–59.2) 61.7 (0.307)
Age (years) (n = 209)
≥10 41 65 71 2 38.7 (30.0–48.2) 97.3 (90.5–99.7) 95.3 (84.5–98.7) 52.2 (43.5–60.8) 62.6 (0.329)
<10 6 13 11 0 31.6 (12.6–56.6) 100 (71.5–100) 100 (54.1–100) 45.8 (25.6–67.2) 56.7 (0.253)
Fever 48 h prior to study (n = 209)
Yes 40 3 2 2 93.0 (81.4–97.6) 50.0 (6.8–93.2) 95.2 (84.2–98.7) 40.0 (5.3–85.3) 89.4 (0.386)
No 7 75 80 0 8.5 (3.5–16.8) 100 (95.5–100) 100 (59.0–100) 51.6 (43.5–59.7) 53.7 (0.084)
History of anti‑malarial drug intake 1 week prior to the survey (n = 208)
Yes 19 37 30 0 33.9 (22.9–47.0 100 (88.4–100) 100 (83.2–100) 44.8 (33.5–56.6) 57.0 (0.264)
No 28 40 52 2 41.2 (30.3–53.0) 96.3 (87.5–99) 93.3 (78.7–98.2) 56.5 (46.3–66.2) 75.6 (0.349)
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is still the gold standard for species identification and 
detecting the severity of malaria by quantifying parasitae-
mia and for differentiation of transmissible stages from 
those responsible for clinical disease [26]. Low specific-
ity of the PfHRP-2/pLDH RDT in the present study is 
in contrast to the high specificity (96.1  %) recorded for 
the CareStart™ HRP-2 RDT tested in an earlier study 
[10], which compared with microscopy for the detec-
tion of falciparum malaria among febrile patients. How-
ever, such low specificity is in agreement with a previous 
study comparing four brands of PfHRP2-based RDTs for 
falciparum malaria diagnosis among febrile patients in 
Malawi, where specificity of 39–68 % was reported [27]. 
It is noteworthy that two cases were positive with both 
LM and PfHRP-2/pLDH RDT but negative by the PCR 
reference method. Although these were considered as 
false-positive results compared to nested PCR as the ref-
erence method, unperceived factors contributing to the 
inhibition of PCR could not be ruled out. Moreover, PCR 
false-negativity has been documented in the literature 
compared to LM [12, 28–30]. The false positivity of the 
RDT in the present study could overestimate the preva-
lence rate by about 25 % as indicated by the PPV (76.9 %) 
compared with nested PCR. This is in agreement with the 
high false-positive rates of P. falciparum using PfHRP-2-
based RDTs reported from Congo [31, 32] and Burkina 
Faso [33]. The PfHRP-2-based RDT false positivity and 
its relatively low PPV could be attributed to the persis-
tence of PfHRP-2 antigenaemia in the blood circulation 
for 4–5  weeks after parasite clearance with successful 
treatment [31, 33, 34]. The possible impact of persistent 
antigenaemia on the specificity of RDT investigated in 
the present could, in part, explain its dropped specific-
ity to 30 % among patients with history of anti-malarial 
drug intake. Furthermore, malaria survey at the peak sea-
sonal transmission, when prevalence rate is >10 % (Lina 
et  al., unpublished data), may partially account for the 
low specificity of PfHRP-2/pLDH RDT in the present 
study. Previous studies showed a negative correlation 
between the specificity of RDTs and malaria prevalence 
[31, 35–37]. False-positive results by PfHRP-2/pLDH 
RDTs can lead to overdiagnosis and subsequent over-
treatment, which may contribute to the emergence and 
spread of drug resistance [38]. Therefore, its combination 
with a more specific test is recommended. Furthermore, 
in addition to genus-specific pLDH, P. falciparum-spe-
cific LDH-based RDTs should be evaluated for screen-
ing of falciparum malaria in Yemen. This may help avoid 
the drawback of PfHRP-2 RDTs resulting from persistent 
antigenaemia in blood after treatment and cure, mini-
mizing the false positivity rate to reasonable and accept-
able levels. However, PfHRP2 positivity in the absence 
of P. falciparum-specific LDH or pan-specific LDH does 
not necessarily mean a false-positive result due to persis-
tent antigenaemia [39]. Although PCR is the most sensi-
tive and specific tool for malaria diagnosis [40], it is not 
practical for routine use in Yemen due to the limited 
resources.
Differences in sensitivity and specificity reflect on 
the estimation of falciparum malaria prevalence in the 
country, particularly among asymptomatic patients. In 
the present study, the overall prevalence of P. falcipa-
rum was three times higher when using PfHRP-2/pLDH 
RDT compared with LM and 16 times higher among 
asymptomatic patients. In this context, Mappin et  al. 
[41] reported a strong, non-linear relationship between 
malaria prevalence rates derived from the LM and RDTs. 
Higher RDT-based prevalence rates were also reported 
from Ethiopia and Tanzania, being two times and three 
times higher than those by LM, respectively [42, 43]. 
Although the sensitivity of RDTs may, to some extent, 
reflect the true prevalence of symptomatic as well as 
asymptomatic-treated cases that cannot be detected by 
LM or PCR in the field over a certain period, the preva-
lence estimates by RDT and LM need to be standardized 
if they are to be used for epidemiological purposes, such 
as mapping [41]. However, it poses a problem for case 
management, where unnecessary treatments could con-
tribute to the emergence and spread of drug resistance. 
The better performance of RDTs over LM in field sur-
veys has also been reported from the Brazilian Amazon 
[44] and Angola [45]. Overall, the findings of the present 
study suggest RDTs as a promising tool for epidemiologi-
cal surveys in Yemen, even in low transmission settings 
and among asymptomatic carriers.
Conclusions
The PfHRP-2/pLDH RDT tested in the present study 
showed a better performance than LM in field survey 
for malaria, even in asymptomatic cases. It showed a 
moderate degree of agreement with nested PCR, with a 
high sensitivity. A major drawback of the RDT is that the 
high false-positivity rate limits its use as an independent 
diagnostic tool for malaria to avoid unnecessary over-
treatment. However, its negative results totally exclude 
falciparum malaria among febrile patients as indicated 
by its 100  % NPV. This can have public health implica-
tions in educating healthcare providers and patients in 
endemic areas to perform RDTs in all cases of fever to 
exclude falciparum malaria before prescribing or taking 
anti-malarial drugs. The low sensitivity of LM indicates 
that a high proportion of malaria cases is missed, lead-
ing to an underestimation of the true malaria prevalence 
in the community. However, LM remains indispensable 
to species identification, differentiation of gametocytes 
from asexual stages and the assessment of the severity of 
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the disease. Furthermore, it is still the gold standard for 
the diagnosis of symptomatic malaria. RDTs should be 
further investigated as rapid malaria-excluding diagnos-
tics among febrile patients in endemic areas.
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